Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma

Cancer

Volumn 103, Issue 9, 2005, Pages 1791-1799

  Blazeby, Jane M ^a,c   Sanford, Emma ^a   Falk, Stephen J ^b   Alderson, Derek ^a   Donovan, Jenny L ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

^c Canynge Hall ^*  (United Kingdom)

Author keywords

Chemotherapy; Esophageal carcinoma; Esophagectomy; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CONVALESCENCE; COUGHING; DEMOGRAPHY; DYSPHAGIA; DYSPNEA; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FATIGUE; FEMALE; HUMAN; LENGTH OF STAY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL STATUS; SURVIVAL TIME; VOMITING;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 17644377901     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20980     Document Type: Article

References (22)

1. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662-1669.
2. Kelsen D, Ginsberg RJ, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localised oesophageal cancer. N Engl J Med. 1998;339:1979-1984.
3. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359:1727-1733.
4. Malthaner R, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer The Cochrane Database of Systematic Reviews, 2003:(4). Article No. CD001556. DOI 10.1002/14651858.CD001556. Available from URL: www. interscience.wiley.com [accessed March 10, 2005].
5. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19:305-313.
6. Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the oesophagus. N Engl J Med. 1997;337:161-167.
7. Nygaard K, Hagen S, Hansen HS, et al. Preoperative radiotherapy prolongs survival in operable oesophageal carcinoma: a randomised, multicentre study of preoperative radiotherapy and chemotherapy: the second Scandinavian trial in oesophageal cancer. World J Surg. 1992;16:1104-1110.
8. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ. A comparison of multimodality therapy and surgery for oesophageal adenocarcinoma. N Engl J Med. 1996;335:462-467.
9. The American Society of Clinical Oncology. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol. 1996;14:671-679.
10. Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA. 2002;288:3027-3034.
11. Velikova G, Booth L, Smith AB, et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol. 2004;22:714-724.
12. Blazeby JM, Farndon JR, Donovan JL, Alderson D. A prospective longitudinal study examining the quality of life of patients with esophageal cancer. Cancer. 2000;88:1781-1787.
13. Zieren HU, Jacobi CA, Zieren J, Muller JM. Quality of life following resection of oesophageal carcinoma. Br J Surg. 1996;83:1772-1775.
14. Brooks JA, Kesler KA, Johnson CS, Ciaccia D, Brown JW. Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary results. J Surg Oncol. 2002;81:185-194.
15. Webb A, Cunningham D, Scarffe JH, et al. Randomised trial comparing epirubicin, cisplatin and fluorouracil versus fluorouracil, doxorubicin and methrotrexate in advanced oesophagogastric cancer. J Clin Oncol. 1997;15:261-267.
16. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-376.
17. Blazeby JM, Alderson D, Winstone K, et al. Development of a EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. Eur J Cancer. 1996;32:1912-1917.
18. Blazeby JM, Conroy T, Hammerlid E, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer. 2003;39:1384-1394.
19. Blazeby JM, Williams MH, Brookes ST, Alderson D, Farndon JR. Quality of life measurement in patients with oesophageal cancer. Gut. 1995;37:505-508.
20. Fayers P, Aaronson NK, Bjordal K, Sullivan M, for the EORTC Study Group on Quality of Life. EORTC QLQ-C30 scoring manual. Brussels: Quality of Life Unit, EORTC Data Centre, 1995.
21. Goodwin PJ, Black JT, Bordeleau LJ, Ganz PA. Health-related quality-of-life measurement in randomized clinical trials in breast cancer - taking stock. J Natl Cancer Inst. 2003;95:263-281.
22. Sprangers MA, Schwartz CE. The challenge of response shift for quality-of-life-based clinical oncology research. Ann Oncol. 1999;10 747-749.